Reference:
[1] Y. Uchida, R. Takazawa, S. Kitayama, and T. Tsujii, “Predictive risk factors for systemic inflammatory response syndrome following ureteroscopic laser lithotripsy.,” Urolithiasis , vol. 46, no. 4, pp. 375–381, Aug. 2018, doi: 10.1007/s00240-017-1000-3.
[2] C. Türk et al. , “EAU Guidelines on Interventional Treatment for Urolithiasis,” Eur. Urol. , vol. 69, no. 3, pp. 475–482, Mar. 2016, doi: 10.1016/j.eururo.2015.07.041.
[3] F. Berardinelli et al. , “Infective complications after retrograde intrarenal surgery: a new standardized classification system.,” Int. Urol. Nephrol. , vol. 48, no. 11, pp. 1757–1762, Nov. 2016, doi: 10.1007/s11255-016-1373-1.
[4] S. A. McDougall EM, Liatsikos EN, Dinlenc CZ, “Percutaneous approaches to the upper urinary tract.,” in Campbell’s Urology , Saunders Company, Philadelphia, 2002, pp. 3327–3452.
[5] S. Yoshida, R. Takazawa, Y. Uchida, Y. Kohno, Y. Waseda, and T. Tsujii, “The significance of intraoperative renal pelvic urine and stone cultures for patients at a high risk of post-ureteroscopy systemic inflammatory response syndrome.,” Urolithiasis , vol. 47, no. 6, pp. 533–540, Dec. 2019, doi: 10.1007/s00240-019-01112-6.
[6] D. A. Wollin et al. , “Antibiotic use and the prevention and management of infectious complications in stone disease.,”World J. Urol. , vol. 35, no. 9, pp. 1369–1379, Sep. 2017, doi: 10.1007/s00345-017-2005-9.
[7] K. Reyner, A. C. Heffner, and C. H. Karvetski, “Urinary obstruction is an important complicating factor in patients with septic shock due to urinary infection.,” Am. J. Emerg. Med. , vol. 34, no. 4, pp. 694–696, Apr. 2016, doi: 10.1016/j.ajem.2015.12.068.
[8] J. S. Wolf, C. J. Bennett, R. R. Dmochowski, B. K. Hollenbeck, M. S. Pearle, and A. J. Schaeffer, “Best practice policy statement on urologic surgery antimicrobial prophylaxis.,” J. Urol. , vol. 179, no. 4, pp. 1379–90, Apr. 2008, doi: 10.1016/j.juro.2008.01.068.
[9] “EAU. European Association of Urology guidelines on urological infections,” 2008, [Online]. Available: http://uroweb.org/guideline/urological-infections/.
[10] N. A. et al. Türk C, Skolarikos A, “EAU-Guidelines-on- B.org/wp-conte, Urolithiasis-,” 2019.
[11] A. Walton-Diaz et al. , “Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study.,” Int. Urol. Nephrol. , vol. 49, no. 1, pp. 31–35, Jan. 2017, doi: 10.1007/s11255-016-1457-y.
[12] O. Koras et al. , “Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study.,” Urolithiasis , vol. 43, no. 1, pp. 55–60, Feb. 2015, doi: 10.1007/s00240-014-0730-8.
[13] T. DA Mariappan P, Smith G, Bariol SV, Moussa SA, “Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study,” J Urol , vol. 173, pp. 1610–1614, 2005.
[14] I. Basmaci and E. Sefik, “A novel use of attenuation value (Hounsfield unit) in non-contrast CT: diagnosis of pyonephrosis in obstructed systems.,” Int. Urol. Nephrol. , vol. 52, no. 1, pp. 9–14, Jan. 2020, doi: 10.1007/s11255-019-02283-2.
[15] K. Sarica, B. Eryildirim, H. Akdere, M. A. Karagoz, Y. Karaca, and A. Sahan, “Predictive value of ureteral wall thickness (UWT) assessment on the success of internal ureteral stent insertion in cases with obstructing ureteral calculi.,” Urolithiasis , Jan. 2021, doi: 10.1007/s00240-020-01233-3.
[16] I. H. Garcia LS and 3rd edn. ASM Press Handbook, “Clinical Microbiology Procedures,” in Clinical Microbiology Procedures , Washington DC, 2010.
[17] T. Cai et al. , “Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship.,” Int. J. Urol. Off. J. Japanese Urol. Assoc. , vol. 25, no. 9, pp. 800–806, Sep. 2018, doi: 10.1111/iju.13723.
[18] C.-W. Lo, S. S.-D. Yang, C.-H. Hsieh, and S.-J. Chang, “Effectiveness of Prophylactic Antibiotics against Post-Ureteroscopic Lithotripsy Infections: Systematic Review and Meta-Analysis.,”Surg. Infect. (Larchmt). , vol. 16, no. 4, pp. 415–420, Aug. 2015, doi: 10.1089/sur.2014.013.
[19] M. Kobayashi, R. Takazawa, Y. Waseda, and T. Tsujii, “How does pre-operative antimicrobial treatment influence the intra-operative culture results and infectious complications in patients with positive baseline bladder urine culture undergoing ureteroscopic lithotripsy?,”Urolithiasis , Jan. 2021, doi: 10.1007/s00240-020-01240-4.
[20] C. He, H. Chen, Y. Li, F. Zeng, Y. Cui, and Z. Chen, “Antibiotic administration for negative midstream urine culture patients before percutaneous nephrolithotomy.,” Urolithiasis , Mar. 2021, doi: 10.1007/s00240-021-01260-8.
[21] S. Özbir, O. Can, H. A. Atalay, H. L. Canat, S. S. Çakır, and A. Ötünçtemur, “Formula for predicting the impaction of ureteral stones.,” Urolithiasis , vol. 48, no. 4, pp. 353–360, Aug. 2020, doi: 10.1007/s00240-019-01152-y.
[22] K. Sarica, B. Eryildirim, H. Akdere, E. Camur, K. Sabuncu, and O. Elibol, “Could ureteral wall thickness have an impact on the operative and post-operative parameters in ureteroscopic management of proximal ureteral stones?,” Actas Urol. Esp. , vol. 43, no. 9, pp. 474–479, Nov. 2019, doi: 10.1016/j.acuro.2018.10.003.
[23] M. Straub et al. , “Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.,” World J. Urol. , vol. 23, no. 5, pp. 309–323, Nov. 2005, doi: 10.1007/s00345-005-0029-z.
[24] G. M. Preminger et al. , “2007 guideline for the management of ureteral calculi.,” J. Urol. , vol. 178, no. 6, pp. 2418–2434, Dec. 2007, doi: 10.1016/j.juro.2007.09.107.
[25] A. Kawashima, C. M. Sandler, R. D. Ernst, S. M. Goldman, B. Raval, and E. K. Fishman, “Renal inflammatory disease: the current role of CT.,” Crit. Rev. Diagn. Imaging , vol. 38, no. 5, pp. 369–415, Oct. 1997.
Table 1. Demographic parameters